Research graph
References from Fractionated Intermediate‐Dose Etoposide Plus G‐ CSF for Peripheral Blood Stem Cell Mobilization in Patients With Lymphoma and Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Prospective Observational Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Indications for Haematopoietic Cell Transplantation for Haematological Diseases, Solid Tumours and Immune Disorders: Current Practice in Europe, 2022
10.1038/s41409-022-01691-w · 2022 · External reference
Factors Affecting Autologous Peripheral Blood Stem Cell Collection in Patients With Relapsed or Refractory Diffuse Large Cell Lymphoma and Hodgkin Lymphoma: A Single Institution Result of 168 Patients
10.1080/10428190701843213 · 2008 · External reference
Factors Influencing Collection of Peripheral Blood Stem Cells in Patients With Multiple Myeloma
1996 · External reference
Poor Mobilization of Peripheral Blood Stem Cells Is a Risk Factor for Worse Outcome in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
10.1080/1042819031000067585 · 2003 · External reference
Comparison of the Efficiency, Safety, and Survival Outcomes in Two Stem Cell Mobilization Regimens With Cyclophosphamide Plus G‐CSF or G‐CSF Alone in Multiple Myeloma: A Meta‐Analysis
10.1007/s00277-020-04376-w · 2021 · External reference
Successful Peripheral Blood Stem Cell Mobilization With Etoposide (VP‐16) in Patients With Relapsed or Resistant Lymphoma Who Failed Cyclophosphamide Mobilization
10.1038/sj.bmt.1701791 · 1999 · External reference
Optimal Chemo‐Mobilization for the Collection of Peripheral Blood Stem Cells in Patients With Multiple Myeloma
10.1186/s12885-019-5285-1 · 2019 · External reference
Effectiveness of Etoposide Chemomobilization in Lymphoma Patients Undergoing Auto‐SCT
10.1038/bmt.2012.216 · 2013 · External reference
Chemomobilization With Etoposide Is Highly Effective in Patients With Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy
10.1016/j.bbmt.2010.06.021 · 2011 · External reference
Cyclophosphamide Plus Etoposide Is a Safe and Effective Mobilization Regimen in Patients With Multiple Myeloma
10.1016/j.transci.2021.103197 · 2021 · External reference
Effective Mobilization With Etoposide and Cyclophosphamide for Collection of Peripheral Blood Stem Cell in Patients With Multiple Myeloma
10.25011/cim.v43i3.34643 · 2020 · External reference
High‐Dose Etoposide Plus Granulocyte Colony‐Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients With Non‐Hodgkin Lymphoma Previously Treated With CHOP‐Based Chemotherapy: A Study From the Consortium for Improving Survival of Lymphoma
10.1016/j.bbmt.2013.10.012 · 2014 · External reference
Chemomobilization With High‐Dose Etoposide and G‐CSF Results in Effective and Safe Stem Cell Collection in Heavily Pretreated Lymphoma Patients: Report From a Single Institution Study and Review
10.1111/ejh.12266 · 2014 · External reference
Phase III Prospective Randomized Double‐Blind Placebo‐Controlled Trial of Plerixafor Plus Granulocyte Colony‐Stimulating Factor Compared With Placebo Plus Granulocyte Colony‐Stimulating Factor for Autologous Stem‐Cell Mobilization and Transplantation for Patients With Non‐Hodgkin's Lymphoma
10.1200/jco.2008.20.7209 · 2009 · External reference
Plerixafor Plus Granulocyte CSF Can Mobilize Hematopoietic Stem Cells From Multiple Myeloma and Lymphoma Patients Failing Previous Mobilization Attempts: EU Compassionate Use Data
10.1038/bmt.2010.54 · 2011 · External reference
Safety and Preliminary Efficacy of Plerixafor (Mozobil) in Combination With Chemotherapy and G‐CSF: An Open‐Label, Multicenter, Exploratory Trial in Patients With Multiple Myeloma and Non‐Hodgkin's Lymphoma Undergoing Stem Cell Mobilization
10.1038/bmt.2009.119 · 2010 · External reference
Motixafortide and G‐CSF to Mobilize Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma: A Randomized Phase 3 Trial
10.1038/s41591-023-02273-z · 2023 · External reference
Interleukin‐8 Induces Rapid Mobilization of Hematopoietic Stem Cells With Radioprotective Capacity and Long‐Term Myelolymphoid Repopulating Ability
10.1182/blood.v85.8.2269.bloodjournal8582269 · 1995 · External reference
Etoposide‐Mediated Interleukin‐8 Secretion From Bone Marrow Stromal Cells Induces Hematopoietic Stem Cell Mobilization
10.1186/s12885-020-07102-x · 2020 · External reference
Single‐Dose Etoposide Is an Effective and Safe Protocol for Stem Cell Mobilization in Patients With Multiple Myeloma
10.1002/jca.21734 · 2019 · External reference
